Medtronic PLC (MDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.41 is considered Undervalued compared with the five-year average of 16.95. The fair price of Medtronic PLC (MDT) is between 104.93 to 128.52 according to relative valuation method. Compared to the current price of 97.66 USD , Medtronic PLC By Undervalued By 6.93%.

Relative Value

Fair Zone

104.93-128.52

Current Price：97.66

6.93%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Medtronic PLC (MDT) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Medtronic PLC (MDT) has a current Price-to-Book (P/B) ratio of 2.53. Compared to its 3-year average P/B ratio of 2.25, the current P/B ratio is approximately 12.31% higher. Relative to its 5-year average P/B ratio of 2.45, the current P/B ratio is about 3.30% higher. Medtronic PLC (MDT) has a Forward Free Cash Flow (FCF) yield of approximately 4.23%. Compared to its 3-year average FCF yield of 4.42%, the current FCF yield is approximately -4.44% lower. Relative to its 5-year average FCF yield of 4.22%, the current FCF yield is about 0.27% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MDT competitors is 6.57, providing a benchmark for relative valuation. Medtronic PLC Corp (MDT.N) exhibits a P/S ratio of 3.33, which is -49.36% above the industry average. Given its robust revenue growth of 8.74%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MDT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MDT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MDT currently overvalued or undervalued?

What is Medtronic PLC (MDT) fair value?

MDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Medtronic PLC (MDT) is between 104.93 to 128.52 according to relative valuation method.

How does MDT's valuation metrics compare to the industry average?

The average P/S ratio for MDT's competitors is 6.57, providing a benchmark for relative valuation. Medtronic PLC Corp (MDT) exhibits a P/S ratio of 3.33, which is -49.36% above the industry average. Given its robust revenue growth of 8.74%, this premium appears unsustainable.

What is the current P/B ratio for Medtronic PLC (MDT) as of Mar 02 2026?

As of Mar 02 2026, Medtronic PLC (MDT) has a P/B ratio of 2.53. This indicates that the market values MDT at 2.53 times its book value.

What is the current FCF Yield for Medtronic PLC (MDT) as of Mar 02 2026?

As of Mar 02 2026, Medtronic PLC (MDT) has a FCF Yield of 4.23%. This means that for every dollar of Medtronic PLC's market capitalization, the company generates 4.23 cents in free cash flow.

What is the current Forward P/E ratio for Medtronic PLC (MDT) as of Mar 02 2026?

As of Mar 02 2026, Medtronic PLC (MDT) has a Forward P/E ratio of 16.41. This means the market is willing to pay $16.41 for every dollar of Medtronic PLC's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Medtronic PLC (MDT) as of Mar 02 2026?

As of Mar 02 2026, Medtronic PLC (MDT) has a Forward P/S ratio of 3.33. This means the market is valuing MDT at $3.33 for every dollar of expected revenue over the next 12 months.

MDT Valuation